EP118: The COVID-19 Situation

Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients. Podcast Summary Introduction Dr. Warrick Bishop is a practicing cardiologist and author dedicated to improving patient care through education about heart health. In this episode, he provides a comprehensive overview of the COVID-19 pandemic, explaining the virus's origins, transmission, risk factors, and practical safety measures during the early stages of the global outbreak. Key Takeaways: COVID-19 (SARS-CoV-2) is a coronavirus related to the 2002 SARS outbreak, but spreads more efficiently while having a less severe prognosis than SARS. Unlike influenza, there is no community-based immunity to COVID-19, allowing it to spread rapidly through populations with no prior exposure. COVID-19 has approximately a 1% death rate, which is 10 times higher than the seasonal influenza death rate of about 0.1%. The virus can be transmitted human-to-human, through contaminated surfaces, and asymptomatically by carriers including children who show no symptoms. Symptoms can take up to 14 days to appear after exposure, making early detection difficult. Elderly individuals over 80 years old have a death rate of 10-15%, significantly higher than the general population, while children under 10 have experienced no fatalities. No antiviral treatment or vaccine exists; current management relies on supportive care, particularly ICU ventilation for severe cases. There is uncertainty regarding ACE inhibitor medications and COVID-19 severity, but discontinuing them without clear evidence is not recommended without consulting a doctor. Particulate masks (P2 and N95) may offer some protection if properly fitted, particularly in high-exposure situations. High-risk groups include elderly individuals (especially over 80), immunosuppressed patients, and those with comorbidities such as diabetes, renal disease, lung disease, and smokers.